• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-05-14

  This study provides a granular analysis of carbapenemase-encoding gene (CEG) prevalence and transmission in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during the COVID-19 pandemic. The findings clarify the genomic localization, transferability, and epidemiology of key CEGs, with direct implications for understanding multidrug resistance and guiding future antimicrobial research.

• Danazol in Endocrine Modeling: Innovations Beyond Puberty Re

  2026-05-14

  Explore Danazol’s role as a potent modulator of steroidogenesis and the HPG axis. This article delivers a unique, protocol-driven analysis for advanced prostate cancer and precocious puberty models, highlighting new assay insights and APExBIO’s high-purity Danazol advantages.

• GPX4-Mediated Glutathione Consumption Drives Platinum Resist

  2026-05-13

  This study elucidates how brain-metastatic lung cancer cells develop pronounced resistance to platinum chemotherapy by upregulating GPX4 and GSTM1, resulting in high glutathione consumption and ferroptosis suppression. The authors identify Wnt/NR2F2 signaling as a key regulator of GPX4 expression, offering mechanistic insight and potential avenues for overcoming chemoresistance in brain metastases.

• Translating Dual Luciferase Insight to Oncology: ZNF263 and

  2026-05-13

  This thought-leadership article, designed for translational researchers, explores how the Dual Luciferase Reporter Gene System (SKU: K1136) from APExBIO advances our mechanistic understanding and experimental rigor in gene expression regulation—exemplified by recent findings on ZNF263-driven autophagy in intrahepatic cholangiocarcinoma (ICC). The article contextualizes these advances within the competitive assay landscape, dissects biological rationale, and offers actionable protocol guidance, while articulating how this resource moves beyond conventional product overviews.

• JAK Inhibitors and Endothelial Dysfunction: Comparative Vasc

  2026-05-12

  This study systematically compares the vascular effects of several JAK inhibitors, including tofacitinib citrate (CP-690550 citrate), on human endothelial cells exposed to inflammatory cytokines. The findings clarify both the anti-inflammatory potential and pro-thrombotic risks across JAK inhibitor classes, with practical implications for immune regulation and inflammatory disorder research.

• Refining In Vitro Cancer Drug Evaluation: Insights from Schw

  2026-05-12

  Schwartz et al. introduce a nuanced framework for in vitro assessment of anti-cancer drug responses, distinguishing between relative viability and fractional viability to better capture both proliferative arrest and cell death. This approach clarifies the interpretation of drug effects in cancer biology research, facilitating more reliable assay design and data analysis.

• Optimizing PI3K/AKT Assays with 740 Y-P (SKU B5246): Data-Dr

  2026-05-11

  Discover how 740 Y-P (SKU B5246) resolves common reproducibility and workflow challenges in PI3K/AKT pathway research. This scenario-driven guide translates validated literature and product data into actionable protocols for cell viability, vesicular trafficking, and neuronal survival assays. Learn why APExBIO’s 740 Y-P stands out for sensitivity and experimental reliability.

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-05-11

  HyperScript™ Reverse Transcriptase from APExBIO redefines cDNA synthesis workflows by combining high thermal stability with sensitivity for low-copy and structurally complex RNA. This article details experimental enhancements, troubleshooting tactics, and direct translation of the latest HCC research into actionable molecular biology protocols.

• HyperScript™ Reverse Transcriptase: Superior cDNA Synthesis

  2026-05-10

  HyperScript™ Reverse Transcriptase, engineered by APExBIO, sets a new standard for cDNA synthesis by enabling robust reverse transcription of RNA templates with extensive secondary structures and low abundance. Leveraging innovations from M-MLV Reverse Transcriptase and recent qPCR assay advances, this enzyme streamlines workflows for sensitive and high-fidelity RNA to cDNA conversion.

• Haloprogin: Broad-Spectrum Topical Antifungal Mechanisms Exp

  2026-05-09

  The foundational 1970 study established Haloprogin as a potent topical antifungal with unique efficacy against dermatophytes, Candida, and certain Gram-positive bacteria. This work defined its broad-spectrum potential, set pivotal MIC/MFC benchmarks, and informed protocol design for both in vitro and in vivo infection models.

• Amt-1 Enhances Antiviral Defense Against Influenza via Nrf2/

  2026-05-08

  This study introduces Amt-1, a novel amantadine derivative, that suppresses influenza A virus by combining direct M2 ion channel inhibition with Nrf2/HO-1-mediated anti-inflammatory effects. Its dual mechanism improves efficacy against resistant strains and limits lung inflammation, marking a significant advance in host-directed antiviral strategies.

• DNase I (RNase-free): Elevating DNA Removal in RNA Workflows

  2026-05-08

  DNase I (RNase-free) from APExBIO sets the benchmark for precise, RNase-free DNA removal in sensitive molecular workflows. Its cation-dependent versatility, robust activity, and proven integration into advanced protein purification protocols empower high-fidelity RNA extraction and downstream assays.

• Bazedoxifene: Precision SERM for Signal Pathway Dissection i

  2026-05-07

  Explore Bazedoxifene, a selective estrogen receptor modulator, as a precision tool for dissecting estrogen and IL-6/GP130 signaling in postmenopausal osteoporosis and oncology research. This article uniquely integrates molecular pharmacology with translational assay guidance.

• Scenario-Driven Lab Solutions with AO/PI Double Staining Kit

  2026-05-07

  This evidence-based guide explores common laboratory challenges in cell viability, apoptosis, and necrosis assays, demonstrating how the AO/PI Double Staining Kit (SKU K2238) delivers robust, reproducible, and data-backed solutions. Scenario-driven Q&As provide actionable insights rooted in peer-reviewed literature and best practices for biomedical researchers and lab technicians.

• Tetraethylammonium Chloride: Applied Workflows in Vascular &

  2026-05-06

  Tetraethylammonium chloride (TEAC) enables precise interrogation of potassium channel function, underpinning a spectrum of workflows from vascular pharmacology to metabolic disease modeling. This article details experimental enhancements, troubleshooting, and advanced use-cases—bridging peer-reviewed insights and APExBIO’s high-purity product reliability.

15588 records 1/1040 page Next 12345 下5页 Last page